Meditation as an Adjunct to Psychotherapy: An Outcome Study

Authors
Han Kutz, Jane Leserman, Claudia Dorrington, Catherine H. Morrison, Joan Z. Borysenko, Herbert Benson
Publication
Psychotherapy and Psychosomatics
43 (4): 209-218
Abstract

The effect of a 10-week meditation program on 20 patients who were undergoing long-term individual explorative psychotherapy was studied. Change in the psychological well-being of the patients and the impact of the program on the process of their psychotherapy was evaluated. Results obtained from the patients’ self-ratings and the therapists’ objective ratings demonstrated a significant and substantial improvement in most measures of psychological well-being.

Related Listings
Daily Relaxation Response Breaks in a Working P...
Authors
Ruanne K. Peters, Herbert Benson, Douglas Porter
Journal
Am. J. Public Health
·
An experiment conducted at the corporate offices of a manufacturing firm investigated the effects of daily relaxation breaks on five self-reported measures of health, performance, and well-being. For 12 weeks, 126 volunteers filled out daily records and reported bi-weekly for additional measurements. After four weeks of baseline monitoring, they were divided randomly into three groups: Group A was taught a technique for producing the relaxation response; Group B was instructed to sit […]
Clinical applications of the relaxation respons...
Authors
Gregg D. Jacobs
Journal
Journal of Integrative and Complementary Medicine
·
Several hundred peer-reviewed studies in the past 20 years have shown that the relaxation response and mind–body interventions are clinically effective in the treatment of many health problems that are caused or made worse by stress. Recent studies show that mind–body interventions may improve prognosis in coronary heart disease and can enhance immune functioning. It is hypothesized that mind–body interventions reduce sympathetic nervous system activation and increase parasympathetic […]
Kundalini Yoga Meditation Versus the Relaxation...
Authors
David Shannahoff-Khalsa, Rodrigo Yacubian Fernandes, Carlos A. de B. Pereira, John S. March, James F. Leckman, Shahrokh Golshan, Mario S.R. Vieira, Guilherme V. Polanczyk, Euripedes C. Miguel, Roseli G. Shavitt
Journal
Frontiers in Psychiatry
Background: Obsessive-compulsive disorder (OCD) is often a life-long disorder with high psychosocial impairment. Serotonin reuptake inhibitors (SRIs) are the only FDA approved drugs, and approximately 50% of patients are non-responders when using a criterion of 25% to 35% improvement with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). About 30% are non-responders to combined first-line therapies (SRIs and exposure and response prevention). Previous research (one open, one randomi […]